Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 N-methyl-D-aspartate Receptor antagonists
1.2.3 Cholinesterase Inhibitors
1.2.4 Dopamine Agonists
1.2.5 Immunomodulatory Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neurodegenerative Disease Treatment Drug Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurodegenerative Disease Treatment Drug Market Perspective (2018-2033)
2.2 Neurodegenerative Disease Treatment Drug Growth Trends by Region
2.2.1 Global Neurodegenerative Disease Treatment Drug Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Neurodegenerative Disease Treatment Drug Historic Market Size by Region (2018-2023)
2.2.3 Neurodegenerative Disease Treatment Drug Forecasted Market Size by Region (2024-2033)
2.3 Neurodegenerative Disease Treatment Drug Market Dynamics
2.3.1 Neurodegenerative Disease Treatment Drug Industry Trends
2.3.2 Neurodegenerative Disease Treatment Drug Market Drivers
2.3.3 Neurodegenerative Disease Treatment Drug Market Challenges
2.3.4 Neurodegenerative Disease Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurodegenerative Disease Treatment Drug Players by Revenue
3.1.1 Global Top Neurodegenerative Disease Treatment Drug Players by Revenue (2018-2023)
3.1.2 Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Players (2018-2023)
3.2 Global Neurodegenerative Disease Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurodegenerative Disease Treatment Drug Revenue
3.4 Global Neurodegenerative Disease Treatment Drug Market Concentration Ratio
3.4.1 Global Neurodegenerative Disease Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurodegenerative Disease Treatment Drug Revenue in 2022
3.5 Neurodegenerative Disease Treatment Drug Key Players Head office and Area Served
3.6 Key Players Neurodegenerative Disease Treatment Drug Product Solution and Service
3.7 Date of Enter into Neurodegenerative Disease Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurodegenerative Disease Treatment Drug Breakdown Data by Type
4.1 Global Neurodegenerative Disease Treatment Drug Historic Market Size by Type (2018-2023)
4.2 Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Type (2024-2033)
5 Neurodegenerative Disease Treatment Drug Breakdown Data by Application
5.1 Global Neurodegenerative Disease Treatment Drug Historic Market Size by Application (2018-2023)
5.2 Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Neurodegenerative Disease Treatment Drug Market Size (2018-2033)
6.2 North America Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Neurodegenerative Disease Treatment Drug Market Size by Country (2018-2023)
6.4 North America Neurodegenerative Disease Treatment Drug Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurodegenerative Disease Treatment Drug Market Size (2018-2033)
7.2 Europe Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2018-2023)
7.4 Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size (2018-2033)
8.2 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurodegenerative Disease Treatment Drug Market Size (2018-2033)
9.2 Latin America Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2018-2023)
9.4 Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size (2018-2033)
10.2 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie Inc.
11.1.1 Abbvie Inc. Company Detail
11.1.2 Abbvie Inc. Business Overview
11.1.3 Abbvie Inc. Neurodegenerative Disease Treatment Drug Introduction
11.1.4 Abbvie Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2018-2023)
11.1.5 Abbvie Inc. Recent Development
11.2 Amneal Pharmaceuticals Inc.
11.2.1 Amneal Pharmaceuticals Inc. Company Detail
11.2.2 Amneal Pharmaceuticals Inc. Business Overview
11.2.3 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Introduction
11.2.4 Amneal Pharmaceuticals Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2018-2023)
11.2.5 Amneal Pharmaceuticals Inc. Recent Development
11.3 Boehringer Ingelheim International Gmbh
11.3.1 Boehringer Ingelheim International Gmbh Company Detail
11.3.2 Boehringer Ingelheim International Gmbh Business Overview
11.3.3 Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Introduction
11.3.4 Boehringer Ingelheim International Gmbh Revenue in Neurodegenerative Disease Treatment Drug Business (2018-2023)
11.3.5 Boehringer Ingelheim International Gmbh Recent Development
11.4 Hoffmann-La Roche
11.4.1 Hoffmann-La Roche Company Detail
11.4.2 Hoffmann-La Roche Business Overview
11.4.3 Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Introduction
11.4.4 Hoffmann-La Roche Revenue in Neurodegenerative Disease Treatment Drug Business (2018-2023)
11.4.5 Hoffmann-La Roche Recent Development
11.5 Merck & Co. Inc.
11.5.1 Merck & Co. Inc. Company Detail
11.5.2 Merck & Co. Inc. Business Overview
11.5.3 Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Introduction
11.5.4 Merck & Co. Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2018-2023)
11.5.5 Merck & Co. Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of N-methyl-D-aspartate Receptor antagonists
Table 3. Key Players of Cholinesterase Inhibitors
Table 4. Key Players of Dopamine Agonists
Table 5. Key Players of Immunomodulatory Drugs
Table 6. Key Players of Others
Table 7. Global Neurodegenerative Disease Treatment Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Neurodegenerative Disease Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Neurodegenerative Disease Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Neurodegenerative Disease Treatment Drug Market Share by Region (2018-2023)
Table 11. Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Neurodegenerative Disease Treatment Drug Market Share by Region (2024-2033)
Table 13. Neurodegenerative Disease Treatment Drug Market Trends
Table 14. Neurodegenerative Disease Treatment Drug Market Drivers
Table 15. Neurodegenerative Disease Treatment Drug Market Challenges
Table 16. Neurodegenerative Disease Treatment Drug Market Restraints
Table 17. Global Neurodegenerative Disease Treatment Drug Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Neurodegenerative Disease Treatment Drug Market Share by Players (2018-2023)
Table 19. Global Top Neurodegenerative Disease Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease Treatment Drug as of 2022)
Table 20. Ranking of Global Top Neurodegenerative Disease Treatment Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Neurodegenerative Disease Treatment Drug Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Neurodegenerative Disease Treatment Drug Product Solution and Service
Table 24. Date of Enter into Neurodegenerative Disease Treatment Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neurodegenerative Disease Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Type (2018-2023)
Table 28. Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Type (2024-2033)
Table 30. Global Neurodegenerative Disease Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Application (2018-2023)
Table 32. Global Neurodegenerative Disease Treatment Drug Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Application (2024-2033)
Table 34. North America Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Neurodegenerative Disease Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Neurodegenerative Disease Treatment Drug Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Neurodegenerative Disease Treatment Drug Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Neurodegenerative Disease Treatment Drug Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size by Country (2024-2033) & (US$ Million)
Table 49. Abbvie Inc. Company Detail
Table 50. Abbvie Inc. Business Overview
Table 51. Abbvie Inc. Neurodegenerative Disease Treatment Drug Product
Table 52. Abbvie Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 53. Abbvie Inc. Recent Development
Table 54. Amneal Pharmaceuticals Inc. Company Detail
Table 55. Amneal Pharmaceuticals Inc. Business Overview
Table 56. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Product
Table 57. Amneal Pharmaceuticals Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 58. Amneal Pharmaceuticals Inc. Recent Development
Table 59. Boehringer Ingelheim International Gmbh Company Detail
Table 60. Boehringer Ingelheim International Gmbh Business Overview
Table 61. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Product
Table 62. Boehringer Ingelheim International Gmbh Revenue in Neurodegenerative Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 63. Boehringer Ingelheim International Gmbh Recent Development
Table 64. Hoffmann-La Roche Company Detail
Table 65. Hoffmann-La Roche Business Overview
Table 66. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Product
Table 67. Hoffmann-La Roche Revenue in Neurodegenerative Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 68. Hoffmann-La Roche Recent Development
Table 69. Merck & Co. Inc. Company Detail
Table 70. Merck & Co. Inc. Business Overview
Table 71. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Product
Table 72. Merck & Co. Inc. Revenue in Neurodegenerative Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 73. Merck & Co. Inc. Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurodegenerative Disease Treatment Drug Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Neurodegenerative Disease Treatment Drug Market Share by Type: 2022 VS 2033
Figure 3. N-methyl-D-aspartate Receptor antagonists Features
Figure 4. Cholinesterase Inhibitors Features
Figure 5. Dopamine Agonists Features
Figure 6. Immunomodulatory Drugs Features
Figure 7. Others Features
Figure 8. Global Neurodegenerative Disease Treatment Drug Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Neurodegenerative Disease Treatment Drug Market Share by Application: 2022 VS 2033
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Neurodegenerative Disease Treatment Drug Report Years Considered
Figure 14. Global Neurodegenerative Disease Treatment Drug Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Neurodegenerative Disease Treatment Drug Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Neurodegenerative Disease Treatment Drug Market Share by Region: 2022 VS 2033
Figure 17. Global Neurodegenerative Disease Treatment Drug Market Share by Players in 2022
Figure 18. Global Top Neurodegenerative Disease Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease Treatment Drug as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Neurodegenerative Disease Treatment Drug Revenue in 2022
Figure 20. North America Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Neurodegenerative Disease Treatment Drug Market Share by Country (2018-2033)
Figure 22. United States Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Neurodegenerative Disease Treatment Drug Market Share by Country (2018-2033)
Figure 26. Germany Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Neurodegenerative Disease Treatment Drug Market Share by Region (2018-2033)
Figure 34. China Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Neurodegenerative Disease Treatment Drug Market Share by Country (2018-2033)
Figure 42. Mexico Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Neurodegenerative Disease Treatment Drug Market Share by Country (2018-2033)
Figure 46. Turkey Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Neurodegenerative Disease Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Abbvie Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2018-2023)
Figure 49. Amneal Pharmaceuticals Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2018-2023)
Figure 50. Boehringer Ingelheim International Gmbh Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2018-2023)
Figure 51. Hoffmann-La Roche Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2018-2023)
Figure 52. Merck & Co. Inc. Revenue Growth Rate in Neurodegenerative Disease Treatment Drug Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed